• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Claudin-18 在胆道肿瘤中的表达。其在肝内胆管癌分类中的意义。

Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma.

机构信息

Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

出版信息

Virchows Arch. 2011 Jul;459(1):73-80. doi: 10.1007/s00428-011-1092-z. Epub 2011 May 24.

DOI:10.1007/s00428-011-1092-z
PMID:21607649
Abstract

Claudin-18 (CLDN18), a tight junction protein specific to stomach and lung, is aberrantly expressed in preinvasive and invasive neoplasms of the pancreas. To investigate the significance of CLDN18 expression in biliary neoplasms, immunohistochemical analysis was performed. CLDN18 expression was frequently observed in the epithelial cells of extrahepatic bile duct carcinomas (90%, n = 99), intrahepatic intraductal papillary neoplasms of the bile duct (IPNBs, 100%, n = 11), and extrahepatic IPNBs (89%, n = 9), while it was less frequent in intrahepatic cholangiocarcinomas (ICCs, 43%, n = 83). Interestingly, CLDN18 expression was also frequently observed in precancerous lesions such as biliary intraepithelial neoplasias (78%, n = 18). Among ICCs, CLDN18-positive cases showed higher frequencies of periductal infiltrative growth, perineural invasion, and lymph node metastasis. Multivariable analysis demonstrated that positive CLDN18 expression was an independent risk factor for lymph node metastasis in ICCs. Furthermore, CLDN18 expression was associated with poor overall survival by univariable analysis, as well as lymph node metastasis. These results suggest that CLDN18 may play an important role in biliary carcinogenesis, and especially in ICCs, it is associated with aggressive behavior and serves as a useful marker for the classification of ICC.

摘要

Claudin-18(CLDN18)是一种特异性表达于胃和肺的紧密连接蛋白,在胰腺的癌前和侵袭性肿瘤中异常表达。为了研究 CLDN18 表达在胆道肿瘤中的意义,进行了免疫组织化学分析。CLDN18 表达在肝外胆管癌(90%,n=99)、肝内胆管内乳头状肿瘤(IPNBs,100%,n=11)和肝外 IPNBs(89%,n=9)的上皮细胞中频繁观察到,而在肝内胆管癌(ICC,43%,n=83)中则较少见。有趣的是,CLDN18 表达也在癌前病变如胆管上皮内肿瘤中频繁观察到(78%,n=18)。在 ICC 中,CLDN18 阳性病例表现出更高的导管周围浸润性生长、神经周围侵犯和淋巴结转移的频率。多变量分析表明,CLDN18 阳性表达是 ICC 淋巴结转移的独立危险因素。此外,CLDN18 表达与单变量分析的总体生存不良以及淋巴结转移相关。这些结果表明 CLDN18 可能在胆道癌发生中发挥重要作用,特别是在 ICC 中,它与侵袭性行为相关,并可作为 ICC 分类的有用标志物。

相似文献

1
Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma.Claudin-18 在胆道肿瘤中的表达。其在肝内胆管癌分类中的意义。
Virchows Arch. 2011 Jul;459(1):73-80. doi: 10.1007/s00428-011-1092-z. Epub 2011 May 24.
2
Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.胆管内乳头状肿瘤与乳头状胆管癌的临床病理对照研究
Histopathology. 2016 Dec;69(6):950-961. doi: 10.1111/his.13037. Epub 2016 Sep 23.
3
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.S100P 免疫组化染色可识别出具有与肝门部和肝外胆管细胞癌相似形态学和分子特征的外周型肝内胆管细胞癌亚群。
Histopathology. 2012 Dec;61(6):1106-16. doi: 10.1111/j.1365-2559.2012.04316.x. Epub 2012 Aug 8.
4
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.基质金属蛋白酶在肝内胆管癌、肝门部(克氏壶腹肿瘤)、肝外胆管中下段癌、胆囊癌和壶腹癌中的表达:基质金属蛋白酶在肿瘤进展和预后中的作用
Turk J Gastroenterol. 2009 Mar;20(1):41-7.
5
Latest advances in the pathological understanding of cholangiocarcinomas.胆管癌病理认识的最新进展。
Expert Rev Gastroenterol Hepatol. 2016;10(1):113-27. doi: 10.1586/17474124.2016.1104246. Epub 2015 Oct 22.
6
Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.肝内胆管癌进展模型的提议:肝门型与外周型的临床病理差异
Am J Surg Pathol. 2007 Jul;31(7):1059-67. doi: 10.1097/PAS.0b013e31802b34b6.
7
Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.肝内胆管癌的发病机制与分类:肝门部大胆管型与外周小胆管型的不同特征
J Hepatobiliary Pancreat Sci. 2015 Feb;22(2):94-100. doi: 10.1002/jhbp.154. Epub 2014 Sep 2.
8
EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.EVI1 表达与肝内胆管细胞癌的侵袭行为相关。
Virchows Arch. 2019 Jan;474(1):39-46. doi: 10.1007/s00428-018-2476-0. Epub 2018 Oct 23.
9
Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.Sox9在致癌过程中的表达及其在肝内胆管癌中的临床意义。
Dig Liver Dis. 2015 Dec;47(12):1067-75. doi: 10.1016/j.dld.2015.08.003. Epub 2015 Aug 18.
10
Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.葡萄糖转运体在肝内胆管癌进展中的不同表达。
Hum Pathol. 2014 Aug;45(8):1610-7. doi: 10.1016/j.humpath.2014.03.008. Epub 2014 Apr 4.

引用本文的文献

1
Claudin18.2 defines a prognostically distinct subgroup of intrahepatic cholangiocarcinoma via CD8 T-cell exclusion.Claudin18.2通过CD8 T细胞排除作用定义了肝内胆管癌预后不同的亚组。
Front Oncol. 2025 Aug 29;15:1636367. doi: 10.3389/fonc.2025.1636367. eCollection 2025.
2
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release.一种靶向Claudin 18.2的亲和力调节型T细胞衔接器显示出强大的抗肿瘤活性,且细胞因子释放有限。
J Immunother Cancer. 2025 Aug 4;13(8):e011857. doi: 10.1136/jitc-2025-011857.
3
Lobular Endocervical Glandular Hyperplasia and Related Glandular Disorders: Current Status of Diagnosis with MR Imaging.

本文引用的文献

1
Predicted expansion of the claudin multigene family.Claudin 多基因家族的预测扩张。
FEBS Lett. 2011 Feb 18;585(4):606-12. doi: 10.1016/j.febslet.2011.01.028. Epub 2011 Jan 26.
2
Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.基于新概念的肝内胆管癌病理分类
World J Hepatol. 2010 Dec 27;2(12):419-27. doi: 10.4254/wjh.v2.i12.419.
3
Immunohistochemical study of claudin 18 involvement in intestinal differentiation during the progression of intraductal papillary mucinous neoplasm.
宫颈管小叶状腺增生及相关腺性疾病:磁共振成像诊断现状
Magn Reson Med Sci. 2025 Jul 1;24(3):332-342. doi: 10.2463/mrms.rev.2024-0198. Epub 2025 Jun 18.
4
Claudin 18 immunohistochemistry in cholangiocarcinoma.胆管癌中Claudin 18免疫组织化学
J Gastrointest Oncol. 2025 Apr 30;16(2):671-678. doi: 10.21037/jgo-2024-925. Epub 2025 Apr 27.
5
Claudin 18.2: a promising actionable target in biliary tract cancers.Claudin 18.2:胆管癌中一个有前景的可作用靶点。
ESMO Open. 2025 Apr 10;10(5):105049. doi: 10.1016/j.esmoop.2025.105049.
6
CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma.紧密连接蛋白18.2:胆管癌潜在的纳米治疗靶点
Front Pharmacol. 2025 Mar 26;16:1559558. doi: 10.3389/fphar.2025.1559558. eCollection 2025.
7
Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma.Claudin-18.2在肝内胆管癌中的预后作用
Virchows Arch. 2025 Mar 28. doi: 10.1007/s00428-025-04081-x.
8
CAR-γδ T Cells Targeting Claudin18.2 Show Superior Cytotoxicity Against Solid Tumor Compared to Traditional CAR-αβ T Cells.与传统的嵌合抗原受体αβ(CAR-αβ)T细胞相比,靶向Claudin18.2的嵌合抗原受体γδ(CAR-γδ)T细胞对实体瘤显示出更强的细胞毒性。
Cancers (Basel). 2025 Mar 17;17(6):998. doi: 10.3390/cancers17060998.
9
Expression of claudin-18.2 in cholangiocarcinoma: a comprehensive immunohistochemical analysis from a German tertiary centre.紧密连接蛋白18.2在胆管癌中的表达:来自德国一家三级中心的综合免疫组织化学分析
Histopathology. 2025 Mar;86(4):640-646. doi: 10.1111/his.15407. Epub 2024 Dec 27.
10
Clinicopathological significance and prognostic values of claudin18.2 expression in solid tumors: a systematic review and meta-analysis.紧密连接蛋白18.2在实体瘤中的表达的临床病理意义及预后价值:一项系统评价与荟萃分析
Front Oncol. 2024 Nov 20;14:1453906. doi: 10.3389/fonc.2024.1453906. eCollection 2024.
免疫组织化学研究 Claudin 18 在导管内乳头状黏液性肿瘤进展过程中肠分化的作用。
Anticancer Res. 2010 Jul;30(7):2995-3003.
4
A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas?基于与胰腺对应物相似性的胆道病变新方法:胆道是不完整的胰腺吗?
Pathol Int. 2010 Jun;60(6):419-29. doi: 10.1111/j.1440-1827.2010.02543.x.
5
Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling.爱泼斯坦-巴尔病毒相关胃癌:通过紧密连接蛋白表达谱分析确定的具有独特胃表型的癌
J Histochem Cytochem. 2009 Aug;57(8):775-85. doi: 10.1369/jhc.2009.953810. Epub 2009 Apr 27.
6
Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.紧密连接蛋白5和7的表达模式可将实性假乳头状瘤与胰腺母细胞瘤、胰腺腺泡细胞肿瘤及内分泌肿瘤区分开来。
Am J Surg Pathol. 2009 May;33(5):768-74. doi: 10.1097/PAS.0b013e3181957bc4.
7
Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.Claudin-1、-2、-3、-4、-7、-8和-10蛋白在胆管癌中的表达
J Histochem Cytochem. 2009 Feb;57(2):113-21. doi: 10.1369/jhc.2008.952291. Epub 2008 Oct 14.
8
Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma.Reg IV和claudin-18的免疫组织化学染色在胃肠道印戒细胞癌的诊断中具有重要作用。
Am J Surg Pathol. 2008 Aug;32(8):1182-9. doi: 10.1097/PAS.0b013e318163a8f8.
9
New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.通过差异基因表达分析鉴定出的胰腺癌新标志物:紧密连接蛋白18和膜联蛋白A8。
Am J Surg Pathol. 2008 Feb;32(2):188-96. doi: 10.1097/PAS.0b013e31815701f3.
10
Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.肝内胆管癌进展模型的提议:肝门型与外周型的临床病理差异
Am J Surg Pathol. 2007 Jul;31(7):1059-67. doi: 10.1097/PAS.0b013e31802b34b6.